All Resources

March 19, 2025

IMC Response to the PMPRB’s March 2025 Guidelines Consultation

Learn more | View

Access to Medicine • March 10, 2025

Increasing Access to Innovative Medicines

Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget

Learn more | View

Access to Medicine • January 30, 2025

Increasing Access to Innovative Medicines

2025 Alberta Budget

Learn more | View

Access to Medicine • January 30, 2025

Increasing Access to Innovative Medicines

2025 Ontario Budget

Learn more | View

Intellectual Property • November 06, 2024

Submission on Global Affairs Canada CUMSA Consultation

Learn more | View

Private Drug Coverage • November 04, 2024

2024 IMC Private Market Policy Summit

Learn more | View

Private Drug Coverage • November 04, 2024

Issues and Opportunities to Modernize Private Drug Plan Sustainability 2024

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • September 11, 2024

IMC Response to the PMPRB’s 2024 Discussion Guide on the Board’s Guidelines

Learn more | View

Access to Medicine • August 15, 2024

IMC Submission on Increasing Access to Innovative Medicines

Learn more | View

Economic Impact • July 29, 2024

The Canadian Research & Development Pharmaceutical Sector 2021

Learn more | View

July 02, 2024

Submission on Proposed Patent Term Adjustment (PTA) Regulations

Learn more | View

Access to Medicine • June 14, 2024

The Canadian Research and Development Pharmaceutical Sector, 2021

This study examines the contribution of the Canadian research and development (R&D) pharmaceutical sector on the Canadian economy in 2021. […]

Learn more | View